ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,007,000 | +177.4% | 16,800 | +211.1% | 0.00% | 0.0% |
| Q1 2021 | $363,000 | -67.5% | 5,400 | -62.5% | 0.00% | -50.0% |
| Q4 2020 | $1,118,000 | -54.6% | 14,400 | -55.8% | 0.00% | -66.7% |
| Q3 2020 | $2,463,000 | +11.3% | 32,583 | -7.6% | 0.01% | 0.0% |
| Q2 2020 | $2,213,000 | +59.2% | 35,260 | +6.8% | 0.01% | +50.0% |
| Q1 2020 | $1,390,000 | -47.5% | 33,000 | -43.4% | 0.00% | -42.9% |
| Q4 2019 | $2,648,000 | +2.9% | 58,340 | +3.6% | 0.01% | 0.0% |
| Q3 2019 | $2,574,000 | +27.6% | 56,328 | +63.7% | 0.01% | +40.0% |
| Q2 2019 | $2,017,000 | -0.9% | 34,400 | -24.2% | 0.01% | -28.6% |
| Q1 2019 | $2,035,000 | +6.6% | 45,373 | -7.6% | 0.01% | +40.0% |
| Q4 2018 | $1,909,000 | -51.3% | 49,100 | -42.4% | 0.01% | -44.4% |
| Q3 2018 | $3,922,000 | -61.6% | 85,220 | -67.1% | 0.01% | -62.5% |
| Q2 2018 | $10,222,000 | 0.0% | 258,773 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $10,222,000 | +72.4% | 258,773 | +11.3% | 0.02% | +9.1% |
| Q3 2017 | $5,929,000 | – | 232,542 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |